Cellectar Biosciences Inc (NASDAQ:CLRB)
| 2.66 Delayed Data As of Sep 29 |  +0.12 / +4.72%Today’s Change | 1.25 Today|||52-Week Range 4.02 | +55.56% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 362.5K | 356.7K | 1.5M | 82.3K | ||
| Operating Expenses | Gross Income | -362.5K | -356.7K | -1.5M | -82.3K | |
| General Expenses | 8.2M | 9.1M | 12.1M | 11.6M | ||
| Research And Development | 5.2M | 4.8M | 7.9M | 6.8M | ||
| Total Operating Expenses | 8.6M | 9.4M | 13.6M | 11.7M | ||
| Non-Operating Expenses | Operating Income | -8.6M | -9.4M | -13.6M | -11.7M | |
| Extraordinary Credit | 3.3M | 3.3M | 22.1K | 62.1K | ||
| Extraordinary Charge | -203.6K | 0.00 | 0.00 | -1.7M | ||
| Interest Expense On Debt | 841.00 | 1.5K | 1.0K | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -5.5M | -6.2M | -13.6M | -13.2M | |
| Preferred Dividend | 0.00 | -- | -1.4M | -2.2M | ||
| Net Income | -5.5M | -6.2M | -13.6M | -13.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 78.2K | 453.7K | 1.4M | 3.0M | |
| Shares To Calculate EPS Diluted | 78.2K | 453.7K | 1.4M | 3.0M | ||
| Earnings Per Share | EPS | -$70.30 | -$13.60 | -$10.70 | -$5.23 | |
| EPS Diluted | -$70.30 | -$13.60 | -$10.70 | -$5.23 | ||
